Identification of potential biomarkers for lung adenocarcinoma: a study based on bioinformatics analysis combined with validation experiments
In this study, TGFBR2 was identified as a biomarker of LUAD, which provided a new idea for the treatment strategy of LUAD and may aid in the development of personalized immunotherapy strategies.
Authors
- Yingdong Lu (ORCID: https://orcid.org/0000-0003-4369-4084)
- Shengchuan Bao (ORCID: https://orcid.org/0000-0003-3742-0220)
- Qiyuan Mao (ORCID: https://orcid.org/0000-0002-3686-2847)
- Ge Zhang (ORCID: https://orcid.org/0000-0002-3116-3246)
- Zehui Chen (ORCID: https://orcid.org/0000-0002-7121-5653)
- Hongsheng Lin (ORCID: https://orcid.org/0000-0002-7967-4838)
- Haiyan Li (ORCID: https://orcid.org/0000-0002-7902-769X)
- Ying Zhang (ORCID: https://orcid.org/0000-0003-3288-0041)
- Chuchu Zhang
- Ying Liu (ORCID: https://orcid.org/0000-0002-7164-962X)
- Yi Liu (ORCID: https://orcid.org/0009-0007-8292-3296)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Guang’anmen Hospital (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Shaanxi University of Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-09-19
- DOI
- https://doi.org/10.3389/fonc.2024.1425895
- Citations
- 2
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.84
Funders
- China Academy of Chinese Medical Sciences